Screener
Rapport Therapeutics, Inc. RAPP Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
FAQ
- What is Rapport Therapeutics, Inc.'s debt-to-equity?
- Rapport Therapeutics, Inc. (RAPP) reported debt-to-equity of 0× in Q2 2026.
- How has Rapport Therapeutics, Inc.'s debt-to-equity changed year-over-year?
- Rapport Therapeutics, Inc.'s debt-to-equity decreased by 46.9% year-over-year, from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Rapport Therapeutics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude